• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Brand Quest
• The New Manager
• BL Club
• Smartbuy
• Books
• Gallery

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth
• Events 2007

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Bangalore, May 21

Mediaid Inc, the marketing subsidiary of Opto Circuits India Ltd (OCI), leading manufacturer of medical diagnostics and interventional products, has received the approval of the Brazilian agency, Agencia Nacional de Vigilancia Sanitaria (equivalent of US Food and Drug Administration) for selling the Pulse Oximetry products (SPO2) such as patient monitors and sensors in that country. The products have already obtained the approval of the USFDA. The Brazilian approval not on ly helped the California-based Mediaid to market the products in the country but will help it sell the products in other countries in the region. Mr Jayesh Patel, Director, OCI, said, “Brazil is the largest medical device market in Latin America and an access into the country’s healthcare industry will help enhance peripheral geography sales too”.

– Our Bureau

More Stories on : Regulatory Bodies & Rulings | Overseas Investments | Medical & Surgical Equipments

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Copyright © 2009, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line